Northern Trust Corp Acquires Shares of 147,776 Septerna, Inc. (NASDAQ:SEPN)

Northern Trust Corp bought a new position in shares of Septerna, Inc. (NASDAQ:SEPN - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 147,776 shares of the company's stock, valued at approximately $3,384,000. Northern Trust Corp owned approximately 0.33% of Septerna as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in SEPN. Tower Research Capital LLC TRC bought a new position in shares of Septerna during the fourth quarter valued at about $25,000. New York State Common Retirement Fund bought a new position in shares of Septerna during the fourth quarter valued at about $32,000. Legal & General Group Plc purchased a new stake in shares of Septerna during the fourth quarter worth about $42,000. Summit Investment Advisors Inc. purchased a new stake in shares of Septerna during the fourth quarter worth about $45,000. Finally, PNC Financial Services Group Inc. bought a new stake in shares of Septerna in the fourth quarter worth about $61,000.

Analyst Ratings Changes

SEPN has been the subject of a number of research reports. Cantor Fitzgerald increased their price target on shares of Septerna from $20.00 to $25.00 and gave the stock an "overweight" rating in a research note on Friday, May 16th. Wells Fargo & Company increased their target price on Septerna from $11.00 to $18.00 and gave the stock an "equal weight" rating in a research report on Friday, May 16th.

Insider Transactions at Septerna

In other Septerna news, Director Alan Ezekowitz acquired 7,491 shares of the stock in a transaction on Tuesday, March 4th. The stock was acquired at an average price of $6.35 per share, for a total transaction of $47,567.85. Following the completion of the transaction, the director now directly owns 24,911 shares of the company's stock, valued at $158,184.85. This trade represents a 43.00% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 4.30% of the company's stock.

Septerna Price Performance

NASDAQ SEPN traded up $0.14 on Thursday, reaching $9.86. 431,444 shares of the stock were exchanged, compared to its average volume of 711,475. Septerna, Inc. has a one year low of $4.17 and a one year high of $28.99. The company's 50-day simple moving average is $7.00 and its two-hundred day simple moving average is $13.38.

Septerna (NASDAQ:SEPN - Get Free Report) last released its earnings results on Thursday, May 15th. The company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.38) by ($0.11). The firm had revenue of $0.22 million for the quarter. As a group, research analysts anticipate that Septerna, Inc. will post -7.11 earnings per share for the current year.

Septerna Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.